BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 26410136)

  • 1. Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.
    Nguyen TC; Cruz MA; Carcillo JA
    Crit Care Clin; 2015 Oct; 31(4):661-74. PubMed ID: 26410136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia-Associated Multiple Organ Failure.
    Nguyen TC
    Crit Care Clin; 2020 Apr; 36(2):379-390. PubMed ID: 32172819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
    Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
    Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathies.
    Rosove MH
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of thrombotic microangiopathies.
    Zheng XL; Sadler JE
    Annu Rev Pathol; 2008; 3():249-77. PubMed ID: 18215115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TTP/HUS and VWF/ADAMTS-13].
    Fujimura Y
    Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary hemolytic uremic syndromes and thrombotic thrombocytopenic purpura].
    Loirat C; Sellier-Leclerc AL; Frémeaux-Bacchi V; Dragon-Durey A; Girma JP; Veyradier A
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S149-61. PubMed ID: 17373216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular biology of thrombotic microangiopathy.
    Tsai HM
    Kidney Int; 2006 Jul; 70(1):16-23. PubMed ID: 16760911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.
    George JN; Vesely SK; Terrell DR
    Semin Hematol; 2004 Jan; 41(1):60-7. PubMed ID: 14727260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology of thrombotic microangiopathies: current understanding].
    Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A
    Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.
    Ono T; Mimuro J; Madoiwa S; Soejima K; Kashiwakura Y; Ishiwata A; Takano K; Ohmori T; Sakata Y
    Blood; 2006 Jan; 107(2):528-34. PubMed ID: 16189276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathies: from animal models to human disease and cure.
    Caprioli J; Remuzzi G; Noris M
    Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathies: towards a pathophysiology-based classification.
    Coppo P; Veyradier A
    Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):36-50. PubMed ID: 19275576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.